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The ability to adapt to changes in the availability of O2 provides a critical advantage to all O2-dependent lifeforms. In mammals it allows
optimal matching of the O2 requirements of the cells to ventilation and O2 delivery, underpins vital changes to the circulation during the transition
from fetal to independent, air-breathing life, and provides a means by which dysfunction can be limited or prevented in disease. Certain tissues
such as the carotid body, pulmonary circulation, neuroepithelial bodies and fetal adrenomedullary chromaffin cells are specialised for O2 sensing,
though most others show for example alterations in transcription of specific genes during hypoxia. A number of mechanisms are known to respond
to variations in PO2 over the physiological range, and have been proposed to fulfil the function as O2 sensors; these include modulation of
mitochondrial oxidative phosphorylation and a number of O2-dependent synthetic and degradation pathways. There is however much debate as to
their relative importance within and between specific tissues, whether their O2 sensitivity is actually appropriate to account for their proposed
actions, and in particular their modus operandi. This review discusses our current understanding of how these mechanisms may operate, and
attempts to put them into the context of the actual PO2 to which they are likely to be exposed. An important point raised is that the overall O2
sensitivity (P50) of any O2-dependent mechanism does not necessarily correlate with that of its O2 sensor, as the coupling function between the
two may be complex and non-linear. In addition, although the bulk of the evidence suggests that mitochondria act as the key O2 sensor in carotid
body, pulmonary artery and chromaffin cells, the signalling mechanisms by which alterations in their function are translated into a response appear
to differ fundamentally, making a global unified theory of O2 sensing unlikely.
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Oxygen is the stuff of life. In aerobic respiration it is used as
the ultimate electron acceptor at the end of a series of oxidation–
reduction reactions that drive production of the ubiquitous high
energy compound ATP, the immediate source of energy for cell
function. O2 is also utilised as a substrate for the synthesis or
degradation of numerous cellular constituents, including many
signalling mediators. Evolution has adapted air-breathing ani-
mals to perform optimally with an ambient PO2 of ∼21 kPa at
sea level, though cellular O2 consumption coupled with the
constraints of diffusion through the tissues means that the
intracellular PO2 may be ∼10% of this, and less in highly
metabolically active tissues. Moreover, whilst the arterial PO2 in⁎ Henriette Raphael House, King's College London, Guy's Hospital Campus,
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is thus a relative term, and is most usefully defined as a condition
in which failure of either delivery or use of O2 limits normal
tissue function. Respiratory and cardiovascular diseases are
commonly associated with hypoxaemia and tissue hypoxia,
which also occur at altitude. A number of mechanisms allow the
body to maintain adequate O2 delivery to the tissues and to adapt
to reduced O2 availability.
Several classical tissues are recognised for their specialised
response to acute hypoxia [1]. Carotid body glomus (type I) cells
stimulate ventilation in response to decreased arterial PO2. Pul-
monary arteries constrict to localised hypoxia (hypoxic pulmo-
nary vasoconstriction, HPV), thereby optimising ventilation–
perfusion matching and gas exchange, whereas systemic arteries
dilate, increasing O2 delivery. Neuroepithelial bodies (NEBs),
clusters of cells exposed to the airway lumen at branch points,
are innervated by the vagus and release neurotransmitters in
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and it has been suggested that they may act in concert with the
carotid body and HPV, especially during the transition to air-
breathing at parturition [2]. Fetal and neonatal adrenomedullary
chromaffin cells (AMCs) release catecholamines in response to
hypoxia, probably an important protective mechanism during
parturition that supports cardiac function and transformation of
the airway epithelium for air-breathing [3]. Notably, the final
response to hypoxia in glomus cells, NEBs and AMCs involves
inhibition of K+ channels, depolarisation, voltage-gated Ca2+
entry and release of neurotransmitters [4]. The situation in pul-
monary artery smooth muscle cells (PASMCs) is more complex
and controversial, with HPV probably involving both voltage-
dependent and -independent Ca2+ entry, Ca2+ release from rya-
nodine-sensitive stores, and Rho kinase-mediated Ca2+ sensiti-
sation [5]. Unlike HPV, hypoxic systemic vasodilatation is often
driven by the O2 requirements of the perfused tissue, and meta-
bolites or mediators produced by the surrounding cells. Never-
theless, isolated systemic arteries do dilate to hypoxia, though
myriad mechanisms have been implicated in this response, in-
cluding effects on ion channels, intracellular Ca2+, pH and
phosphate, Ca2+ sensitivity and cross-bridge cycling [6–9]. It is
therefore unwise to consider hypoxic systemic vasodilatation as
a single phenomenon.
It is likely that most other cell types also respond to hypoxia,
especially if it is prolonged. Hypoxia causes increased tran-
scription of a large number of hypoxia-sensitive genes, leading
for example to increased production of erythropoietin in the renal
cortex and consequently an increase in red cell mass, and in-
creased expression of growth factors such as vascular endothelial
growth factor (VEGF), a key driver of angiogenesis. Hypoxia
also modulates the balance between aerobic and anaerobic (gly-
colytic) energy production in numerous tissues, so reducing O2
demand at the expense of reduced efficiency of substrate use.
The existence of these homeostatic processes obviously im-
plies an ability to sense deviations in [O2] from the optimum,
and/or the metabolic consequences of such deviations. It is now
recognised that a number of mechanisms with different sensi-
tivities may effectively act as O2 sensors (though it may not
always be O2 that is actually sensed) and coexist in the same cell,
though there is controversy as to their relative importance and
signalling pathways between and within individual tissues, and
potentially between species [1,4,10,11]. An important consider-
ation when determining the physiological role of such sensors is
how well their O2 sensitivity matches that of their effector
response(s). In this review I discuss the mechanisms of several
proposed O2 sensors, and attempt to correlate their apparent O2
sensitivity to that of their effectors, and indeed to the likely range
of PO2 present in the tissue or location of interest. In broad terms
O2 sensor mechanisms can be differentiated into those depen-
dent on perturbations of mitochondrial function and energy state
(bioenergetic), and those on perturbations of O2-dependent
synthesis or degradation of mediators (biosynthetic), though in
places this distinction becomes blurred.
Note that throughout this review I use the term P50 rather
than KM to denote the PO2 causing half-maximal responses of
O2 sensitive mechanisms, as the response may not alwaysstrictly adhere to Michaelis–Menten kinetics. I have followed
the convention of using PO2 instead of the technically more
correct [O2], as the former is more immediately comprehen-
sible. However, as biochemical determinations of KM are
usually given in terms of concentration, the P50s of the putative
O2 sensors are shown in terms of both PO2 and [O2].
2. Bioenergetic O2 sensing mechanisms
2.1. Mitochondria
Mitochondria are the largest consumers of O2, and as such
are the key determinants of cytosolic PO2 and the O2 gradient
between alveoli and cytosol. They are also recognised as im-
portant signalling organelles [12]. Mitochondria are therefore
prime contenders for the location of a key O2 sensor, and over
the years a substantial body of evidence has developed sup-
porting this conjecture. There is for example a wide consensus
that inhibitors of oxidative phosphorylation or procedures that
modify mitochondrial function strongly affect O2 sensing in
PASMCs, glomus cells and AMCs [1,4,13–17], though not in
NEBs [2,18]. Significant controversy exists however concern-
ing the signalling mechanisms that link mitochondrial function
to the effectors, and there are currently three main hypotheses of
mitochondrial O2 sensing, involving cytosolic redox state, re-
active O2 species (ROS) and energy state respectively (Fig. 1). It
is helpful to review mitochondrial function at this point so that
these hypotheses can be evaluated in context.
The Kreb's cycle and β-oxidation of fatty acids generate
reduced nicotinamide adenosine dinucleotide (NADH) and
flavin adenine dinucleotide (FADH2) which are oxidised by
the electron transport chain (ETC) in the mitochondrial inner
membrane. The operation of the ETC is outlined in Fig. 2.
Briefly, oxidation of NADH in complex I and FADH2 in
complex II leads to transfer of 2 electrons to ubiquinone to form
ubiquinol. This is reoxidised by complex III (cytochrome bc1) in
two stages. One electron is first removed by the Rieske Fe–S
group leaving ubisemiquinone, and transferred via cytochromes
c1 and c to complex IV (cytochrome c oxidase, COX). The
ubisemiquinone left behind is reoxidised to ubiquinone by cyto-
chrome bL, which passes the remaining electron to cytochrome
bH. This reduces ubiquinone first to ubisemiquinone and then
back to ubiquinol, which re-enters complex III. Oxidation of one
molecule of ubiquinol back to ubiquinone thus takes 2 cycles of
complex III, with sequential transfer of its 2 electrons to cyto-
chrome c. These electrons are finally and sequentially trans-
ferred by cytochromes a and a3 in complex IV to O2 to form
water. Operation of complexes I, III and IV cause extrusion of
protons thus generating the mitochondrial membrane potential
(ΔΨm) and proton gradient (ΔpH) which drive the F0F1 ATP
synthetase (Fig. 2; [19]). The mechanisms of the ETC are such
that at various points single electrons can be lost to molecular
O2 to form reactive O2 species (ROS) in the form of superoxide,
primarily from reduced flavins in complex I and ubisemiqui-
none in both Qo (intermembrane space) and Qi (matrix) sides
of complex III; as much as 3% of electron flux through the
ETC may be constitutively lost in this way [20]. Superoxide is
Fig. 1. Summary of bioenergetic O2 sensor mechanisms mediated by hypoxia-dependent alterations of electron flux through the electron transport change.
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cytosolic and mitochondrial superoxide dismutase (CuZnSOD
and MnSOD respectively); if ROS are involved in signalling
then peroxide is the likely signalling moiety.
The P50 of cytochrome aa3 is reported to be ∼0.07 kPa PO2
(∼0.7 μM) as measured in cells from systemic tissues [21]. If
[O2] becomes rate limiting all components of the ETC proximal
to complex IV will become more reduced, leading to accu-
mulation of upstream reducing equivalents and a more reduced
cytosolic redox state, as reflected by an increased ratio of the
important redox pair of reduced and oxidised glutathione (GSH/
GSSG). ATP production would only be expected to fall ifΔΨm
and ΔpH were sufficiently decreased [22]. It should be noted
however that the “near equilibrium” hypothesis of Erecinska
and Wilson predicts that cytochrome c and proximal compo-
nents of the ETC will become reduced even well above the P50Fig. 2. Basic function of the mitochondrial electron transport chain, illustrating com
production. QH2, ubiquinol; QH
U, ubisemiquinone; R, Rieske Fe–S protein; c, cytoc
and bL.as the PO2 decreases, if sufficient reducing equivalents are
available as substrate, yet without a decrease in electron trans-
port through COX [23,24]. Consistent with the concept of
inhibition of mitochondrial function, increased cytosolic GSH/
GSSG and NADH/NAD+ ratios have indeed been reported in
O2 sensitive tissues during moderate hypoxia [25–27], although
others have suggested little change in global redox state [28].
What happens to mitochondrial ROS production in hypoxia is
open to question and the source of much debate [28–32].
Whereas a fall in [O2] might be expected to cause a decrease
simply because there is less O2 from which superoxide can be
formed, reduction of the proximal ETC will increase the con-
centration of electron donors and thus promote electron transfer
toO2; as superoxide production is proportional to [O2]× [electron
donor] [20], it could therefore theoretically go up or down during
hypoxia depending in part on the relative changes to theseplexes I, II, III and IV, the ubiquinone (Q) cycle and sites of superoxide (UO2
−)
hrome c; c1, cytochrome c1; aa3, cytochromes a and a3; bH/L, cytochromes bH
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depend on the relative expression of COX to proximal compo-
nents of the ETC [21]. What happens to mitochondrial ROS
production in hypoxia is a critical point, as opposite changes are
postulated by two of the three main hypotheses of mitochondrial
O2 sensing.
2.2. Energy state
In investigating the role of mitochondria in O2 sensing,
considerable use has been made of pharmacological inhibi-
tors of the ETC. As discussed above, a large number of
studies in several tissues have shown that inhibition of
oxidative phosphorylation has profound effects on O2
sensing, leading to the concept that changes in energy state
may underlie the final response to hypoxia. However, there
are disparities between tissues as to the precise effects of
inhibitors acting at different points in the ETC. In the glomus cell
inhibitors of both the proximal (e.g. rotenone, complex I) and
distal (e.g. cyanide, cytochrome oxidase) ETC are known to
mimic hypoxia and cause inhibition of K+ channels, as does the
F0/F1 synthetase inhibitor oligomycin [14,33,34], leading to the
proposal that a fall in ATP production mediates the response. In
AMCs however, although rotenone also mimics hypoxia and
promotes depolarisation and secretion, cyanide either has no
effect or promotes hyperpolarisation and reduces secretion [17],
predicating against a signalling role for energy state in this tissue.
The situation is less clear in PASMCs, as although there is
agreement that proximal ETC inhibitors abolish O2 sensing and
responses associated with HPV, only some reports suggest that
they mimic hypoxia [35–37], whereas others are adamant that
they do not [15,27,38,39]. Reports on the effects of cyanide on
PASMCs are variable, with low concentrations either having no
effect or augmenting HPV, and high concentrations abolishing
HPV without mimicking hypoxia [15,27,36,38,39]. In addition,
we find that oligomycin, like high concentrations of cyanide,
abolishes HPV in small pulmonary arteries without causing
constriction [40], essentially the opposite of what occurs in
glomus cells [14,33]. Again, this would tend to suggest a
signalling mechanism that is unrelated to ATP production in
PASMCs.
Cytosolic [ATP] is generally well maintained in the face of
ADP accumulation by the adenylate kinase reaction, where two
ADP are used to produce one molecule of ATP and one of AMP.
As the AMP/ATP ratio thus varies close to the square of the
ADP/ATP ratio, it is therefore a very sensitive indicator of
energy state. AMP kinase is an ubiquitous energy sensor that is
activated by the AMP/ATP ratio via a multi-site, synergistic
mechanism, making it exquisitely sensitive to energy state [41].
It is known to modulate many cellular functions but in particular
ATP production and consumption, including upregulation of
glucose uptake and glycolysis in hypoxia [41]. Convincing
evidence has recently been presented that in glomus cells AMP
kinase provides a direct link between suppression of mitochon-
drial function by hypoxia and the inhibition of K+ channels
[42,43]. It has also been proposed that AMP kinase sub-serves
the same function in PASMCs, but in this case via modulationof Ca2+ release from ryanodine-sensitive stores [42]. However,
on balance the evidence from mitochondrial inhibitor studies
does not appear to be consistent with an energy state based
hypothesis either for HPV or AMCs (see above). Glycolysis
provides a significant proportion of ATP in PASMCs, especially
in hypoxia, and is rate limited by glucose entry [7]. Thus a
further point predicating against an energy state/AMP kinase
hypothesis for HPV is that the latter is selectively inhibited by
hypoglycaemia or inhibition of glycolysis, and potentiated by
hyperglycaemia [27,44], the opposite of what would be ex-
pected if a fall in ATP production was the initiating signal. In
contrast and consistent with the AMP kinase hypothesis, hy-
poglycaemia potentiates the hypoxic ventilatory response in
humans [45]. Indeed, some studies have suggested that the
carotid body responds to hypoglycaemia alone and may play a
role in glucose homeostasis, though this is not universally
accepted [46–49].
2.3. Redox state and ROS
Hypotheses based on redox state and mitochondrial ROS
production are associated with effects of mitochondrial inhi-
bition that are unrelated to energy state per se. The Redox
hypothesis of HPV developed by Weir and Archer [25,50,51]
proposes that during hypoxia inhibition of oxidative phosphor-
ylation and decreased ROS production cause the cytosol of
PASMCs to become more reduced, leading to inhibition of
redox-sensitive KV channels, depolarisation and Ca2+ entry via
voltage-dependent Ca2+ channels. Inhibition of the proximal
ETC would therefore be expected to mimic hypoxia (as indeed
reported by supporters of this hypothesis, [35–37]), whereas
inhibition of the distal ETC might be expected to suppress the
effects of hypoxia, as this promotes ROS production. Studies
using exogenous oxidising and reducing agents tend to support
this hypothesis, as their reported effects (e.g. modulation of K+
channel activity) are as predicted if hypoxic-signalling is via a
more reduced cytosolic environment [50,52–54]. A similar
hypothesis has been proposed for O2 sensing in AMCs, al-
though in this case there is good evidence that it is the fall in
mitochondrial ROS production that causes inhibition of K+
channels and depolarisation during hypoxia, rather than any
change in redox state [17]. Redox state has been reported to play
no role in glomus cell O2 sensing [28,55].
In direct contrast to the above, the ROS hypothesis de-
veloped by Schumacker [13,31,56] proposes that generation of
ROS from complex III of the ETC increases during hypoxia in a
number of cell types including cardiomyocytes, hepatocytes and
PASMCs, and that this ROS acts as the signalling mediator for
subsequent responses, ranging from HPV and elevation of in-
tracellular Ca2+ to increased transcription of hypoxia-sensitive
genes. Inhibition of the proximal ETC would prevent this rise in
ROS production, and thus studies showing that such inhibition
blocks the response to hypoxia without mimicking it are entirely
consistent with this hypothesis [15,27,38,39], as are studies
showing potentiation of HPV or the associated rise in intra-
cellular [Ca2+] following treatment with low concentrations of
cyanide [15,27,38]. Furthermore, the large majority of studies
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and catalase, or overexpression of catalase or glutathione per-
oxidase (which degrade peroxide) suppress HPV and/or the
hypoxia-induced elevation in intracellular [Ca2+], but impor-
tantly do not mimic hypoxia [15,38,57–59].
It is interesting to note that AMCs clearly differ from
PASMCs in this respect as well as in terms of the effect of
ETC inhibitors, as in AMCs antioxidants are reported to mimic
hypoxia, whilst exogenous peroxide suppresses the effects of
hypoxia [17]. Moreover, in AMCs application of the complex
II substrate succinate reverses the depolarisation and activation
induced by the complex I inhibitor rotenone, presumably by
bypassing the block and restoring electron flux to complex III,
thus increasing ROS formation [17]. In pulmonary artery
however exactly the same procedure restores HPV [27], i.e. it
has the opposite effect on O2 sensing. The latter is an
additional argument against the Redox and energy state/AMP
kinase hypotheses for HPV, as it would also be expected to
restore both ROS and ATP production. However, this does not
rule out a role for AMP kinase in HPV, as several studies have
shown that AMP kinase can be activated by ROS and
oxidative stress in the absence of any change in nucleotides
[e.g. [60,61,62]].
Unfortunately, limitations of available probes have made
direct measurements of ROS equivocal and controversial, with
both decreases [e.g. [17,36,37]] and increases [e.g. [13,39,59,63]]
in ROS production reported during hypoxia, sometimes in similar
preparations and using the same probes. However, a novel ratio-
metric, redox-sensitive fluorescence resonance energy transfer
(HSP-FRET) probe has recently been used to show an increase
in ROS in cultured PASMCs [59], and hypoxia is reported to
cause formation of DNA base oxidation products and membrane
lipid peroxidation in pulmonary artery endothelial and PASMCs
[64–66], indicative of increased oxidant stress.
3. Biosynthetic O2 sensing mechanisms
3.1. NADPH oxidases
The phagocytic NADPH oxidase (NOX2) consists of the
integral membrane sub-units gp91phox and p22phox that form
cytochrome b558, and the cytosolic organiser sub-unit p47
phox
which translocates p67phox and Rac from the cytoplasm to cause
activation. In NOX1 and 3 other isoforms substitute for gp91phox
and possibly other sub-units but are mechanistically similar to
NOX2; however NOX4 apparently does not require the cyto-
solic sub-units for activation [67]. The primary purpose of at
least NOX2 is to generate superoxide from molecular O2, using
NADPH as an electron donor; the P50 is reported to be∼1.7 kPa
PO2 (∼18 μM) [68]. It is to be expected therefore that hypoxia
should cause a fall in NOX-derived ROS, and it has been
proposed that this underlies O2 sensing in a number of tissues
including NEBs, glomus cells and PASMCs [18,69,70]. How-
ever, some studies have shown that hypoxia causes an appar-
ently paradoxical increase in NOX activity and ROS production
in PASMCs [71] and glomus cells [72]; this could be as a result
of a concomitant increase in NADPH [73,74] (Fig. 3).There is strong evidence that NOX2 and a reduction in ROS
underlies the response to hypoxia in NEBs, with consequent
inhibition of K+ channels and depolarisation, an important
component of this evidence being loss of O2 sensing in gp91-
phox-deficient mice [18,75,76]. In contrast, O2 sensing was
retained in glomus cells, AMCs and lung from mice lacking
gp91phox [39,77–79], effectively ruling out any role for NOX2
in these tissues. Although knockout of p47phox did not abolish
O2 sensing in either lung or glomus cells, in the former it
caused inhibition of a rapid transient phase of HPV [39], whilst
in glomus cells it enhanced O2 sensitivity, and abolished the
hypoxia-induced elevation in ROS [72]. It has been suggested
that the latter represents an important modulatory role for a
non-phagocytic NOX in glomus cells [73]. Interestingly,
NOX4 has been shown to confer O2 sensitivity upon TASK-
1 channels in a model cell system [80], and TASK-1 has been
implicated in O2 sensing for both PASMCs and glomus cells
[34,81,82]. The P50 for activation of TASK-1 in glomus cells is
reported to be 1.6 kPa PO2 [81], and whilst I could find no
value for the P50 of NOX4, this is remarkably similar to that of
at least NOX2.
3.2. Heme oxygenases
Three isoforms of heme oxygenases (HO) have been identi-
fied, HO-1, -2 and -3, although only HO-2 is constitutively
expressed. HO degrades heme to CO, biliverdin and Fe(II) in
the presence of O2 and NADPH [83]; it is reported to have
an exceptionally high O2 affinity, with a P50 for HO-2 of
∼0.001 kPa PO2 (0.013 μM) and for HO-1 ∼0.0035 kPa PO2
(0.036 μM) [84]. It has recently been proposed that a novel
association between HO-2 and large conductance, Ca2+-acti-
vated K+ (BK) channels in the membrane underlies O2 sensing
in glomus cells, and possibly elsewhere [85,86]. This hypoth-
esis proposes that HO-2-derived CO maintains BK channel
activity in normoxia, but in hypoxia the reduction in CO for-
mation leads to channel closure and depolarisation. Although
one study in HO-2−/− mice has reported that the ventilatory
response to hypoxia was indeed attenuated [87], a subsequent
report showed no effect on glomus cell O2 sensitivity, or indeed
a role for BK channels in O2 sensing [88]. However, these
discrepancies could well reflect species differences, as part of
the original study was performed in rat. It has been suggested
that HO-2 may also be involved in PASMC O2 sensing, as
HO-2−/− mice had ventilation/perfusion mismatch and were
hypoxaemic [87], but there is little evidence that BK channels
are involved in HPV [5], and inhibition or knockdown of HO-2
facilitates HPV [89].
3.3. Cytochrome P-450 monooxygenases
Cytochrome P-450 monooxygenases (CYP) include a vast
number of homologous O2 sensitive proteins that oxidise a
wide range of compounds, although in terms of distal
mediators attention tends to have focused on those metabolis-
ing arachidonic acid. Of these, ω-hydroxylases generate ω-
terminal hydroxyeicosatetraenoic acids (19- and 20-HETE),
Fig. 3. Summary of biosynthetic O2 sensor mechanisms. Boxes surrounded and connected by dashed lines represent potential interactions with bioenergetic O2 sensor
mechanisms; if these represented the major mechanisms then NOX and CYP would no longer be regarded as O2 sensors, but as part of the effector pathway. In the case
of PHDs however the bioenergetic pathway could be parallel or synergistic.
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(EETs); mid-chain hydroxylation of arachidonic acid also
forms HETEs, including 11-, 13- and 15-HETE [90]. The
P50 for ω-hydroxylases is reported to be relatively high at
∼9 kPa PO2 (90 μM) and greater still for epoxygenases [91].
Though this suggests that [O2] should be rate limiting,
certainly in the cytosol, and that a fall in PO2 would
therefore reduce synthesis of product, there is in fact
evidence that arachidonic acid availability is the primary
limiting factor [90]. As hypoxia and ROS both activate
phospholipase A2 and increase arachidonic acid liberation
from membrane lipids [92], this could potentially mean that
hypoxia stimulates rather than inhibits CYP activity, at least
for some isoforms.
Numerous reports have in fact suggested that CYP meta-
bolites contribute to the response to hypoxia in the systemic
microvasculature and endothelium [90,93,94], and may
contribute to HPV [95]. It has recently been proposed that
a CYP 2C9 epoxygenase product plays a major role in both
HPV and the vascular remodelling associated with chronic
hypoxia [96], as both were suppressed by a novel inhibitor
of CYP 2C9, and overexpression of CYP 2C9 increased
pulmonary vascular tone. However, other CYP inhibitors
that also block CYP 2C9 do not cause selective inhibition
of HPV [97,98], nor do they affect O2 sensing in glomus
cells [55].
3.4. HIF-1 and prolyl and asparaginyl hydroxylases
The transcription factor hypoxia-inducible factor-1 (HIF-1) is
responsible for many of the alterations in gene expression that
allow adaptation to prolonged hypoxia, for example those
underlying erythropoiesis [99], angiogenesis [100], and expres-
sion of ion channels [101]. HIF-1 is formed of a constitutivelyexpressed HIF-1β sub-unit and an O2 regulated HIF-1α sub-
unit. In normoxia HIF-1α is rapidly degraded because it is
ubiquitinated by a complex containing von Hippel–Lindau
(vHL) protein; in hypoxia HIF-1α is stabilised because vHL
binding requires O2-dependent hydroxylation of proline
residues on HIF-1α by Fe(II) and 2-oxoglutarate requiring
prolyl hydroxylase domain proteins (PHD) [102]. This of
course implies that HIF-1α is being constitutively synthesized;
its level of expression therefore reflects the balance between
rates of formation and degradation. HIF-1α activity also
requires transactivation, which is prevented in normoxia by
hydroxylation of an asparagine residue by the asparaginyl
hydroxylase FIH-1 (factor inhibiting HIF-1) [103]. Thus
hypoxia allows both stabilisation and transactivation of HIF-
1α, and promotes transcription. Both PHDs and FIH-1
apparently have a particularly low affinity for O2, with the
P50 for PHDs reported to be as high as∼22 kPa PO2 (230 μM),
and for FIH-1 ∼9 kPa PO2 (90 μM) [104].
Other factors such as nitric oxide (NO) and ROS can lead
to HIF-1α stabilisation [105,106], and use of ETC inhibitors
or cells with dysfunctional mitochondria has led to the
suggestion that during hypoxia an increase in mitochondrial-
derived ROS is essential for stabilisation [107–109]. How-
ever, an alternative and experimentally convincing interpreta-
tion of such studies is that inhibition of mitochondrial
function prevents HIF-1 stabilisation during hypoxia because
it reduces O2 consumption and so increases O2 availability
[62,110], though this cannot account for reports that
antioxidants suppress hypoxia-induced HIF-1α stabilisation
[109,111]. Interestingly, although 1 mM cyanide increased
basal expression of HIF-1α in HeLa cells by ∼50% in
normoxia, it had little effect on the increase in expression
induced by hypoxia and did not alter the P50 for HIF-1α
expression [112] (and see below).
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4.1. Distribution of PO2 values in the body
Delivery of O2 to the cells is driven by the concentration
gradient set up by consumption in the mitochondria (Fig. 4); O2
is delivered by convection in the airways and blood vessels, and
diffusion across the alveolar-capillary membrane and between
blood and mitochondria. Measurements of PO2 in the airways
and major blood vessels are relatively easy, and biochemical
studies provide reasonable estimates of cytosolic PO2; this will
vary between tissues according to rates of O2 consumption and
delivery, but is likely to be in the region of 1–2 kPa [21,22]. O2
sensitive microelectrodes and more recently phosphorescence
quenching methods have been used to provide estimates of PO2
in the microvasculature and tissues [113]. These suggest that the
median PO2 in systemic arterioles is ∼7 kPa, falling to ∼3–
4 kPa in precapillary arterioles and capillaries. The PO2 gradient
between capillaries and tissue interstitium appears to be small or
non-existent in most tissues examined, suggesting that most O2
exchange occurs in small arterioles rather than capillaries as
originally surmised [113–115] (and Fig. 4). A significant pro-
portion of the O2 gradient across the arteriolar wall appears to be
due to O2 consumption by the walls themselves, specifically by
the endothelium, and this may also account for part of the fall in
PO2 between large arteries and arterioles [113,115]. Notably, the
trans-arteriolar wall PO2 gradient has been reported to be
reduced in endothelial NO synthase−/− mice, and tissue PO2
increased [116]. An important point in terms of this review is that
as the PO2 of arterial blood falls during respiratory hypoxia, that
in the arterioles and tissues falls in strict proportion [114].
The distribution of PO2 has implications concerning the
actual PO2 seen by O2 sensors in different locations. ConsistentFig. 4. Representation of the regional distribution of PO2 from the airways to the c
derived from various sources, including [21,22,113–115,117]. The bars show the regi
in small arterioles (see text). The diagram also shows the approximate values for the P
shown for comparison. Cyt aa3, cytochrome aa3; CYP ω, cytochrome P-450 ω-h
NADPH oxidase, gp91phox isoform; PHDs, prolyl hydroxylase domain proteins.with the data shown above, exchange vessels in the carotid body
are reported to have a PO2 of ∼3 kPa in normoxia [117]. The
precise PO2 seen by the small pulmonary resistance arteries
(50–400 μm diameter) that primarily control pulmonary vas-
cular resistance is unclear. It is however well known that HPV is
related more strongly to the alveolar rather than mixed venous
PO2, supported by findings that there is considerable gas
exchange between the alveoli and small pulmonary arteries
[118,119]. NEBs are also likely to be exposed to a PO2 close to
that in the alveoli. It should be noted however that NEBs and
AMCs are thought to have their primary roles in the fetus and
during parturition, and the fetal arterial PO2 is ∼5 kPa.
4.2. Correlation of sensor O2 sensitivity with regional PO2
An important consideration for the following discussion is
that the observed response of O2 sensitive tissues tends to be
correlated to the PO2 of the arterial blood for experiments in
vivo, or that of the perfusate or superfusate for experiments in
vitro. This may significantly overestimate the true P50 of the O2
sensor, particularly in superfused multi-cellular preparations
where the diffusional distance to the core may be much greater
than in a preparation perfused via its vasculature [120]. Similar
considerations apply to cells in culture, especially when using
standard gas-impermeable culture dishes, where the extensive
diffusional distance from the gas phase to the cells (∼2–5 mm)
can lead to a substantial O2 gradient even where cellular O2
consumption is relatively low [110].
Whilst bearing the above in mind, it is still edifying to show
the P50 reported for the various O2 sensing mechanisms in the
context of the PO2 found in different regions (Fig. 4). It is
immediately apparent that the reported P50s for cytochrome
aa3, HO and PHDs fall outside the extremes of PO2 in relevantytosol. The thickness of the line represents variation between reports; data was
ons where O2 transport is mediated via convection or diffusion; both are involved
50 of key O2 sensitive mechanisms; eNOS (endothelial nitric oxide synthase) is
ydroxylase; FIH-1, factor inhibiting HIF-1; HO-2, heme oxygenase 2; NOX2,
Fig. 5. Panel A: Theoretical model of the activity of proposed O2 sensor
mechanisms over a physiologically relevant range of PO2, calculated assuming
hyperbolic, Michaelis–Menten kinetics, and substrates and co-factors other than
O2 in excess (if applicable). Panel B shows the calculated change in sensor
activity predicted for a halving of the PO2 from 8, 4, 1 and 0.3 kPa, approx-
imating to normoxic values for alveoli/arteries, tissue, cytosol, and possibly
mitochondria. Values for the P50s were taken from: PHDs and FIH-1 [104];
CYP ω-hydroxylase [91]; NOX2 [68]; cytochrome aa3 (COX) [21]; and HO-2
[84].
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sensors in vivo. However, such an examination may be mis-
leading for a number of reasons. Firstly, the P50 of the sensor
mechanism itself (rather than that of its effectors) is rarely
examined in situ, where it may be modulated by a number of
factors (see below). Secondly, it could be considered that the
most important function of any O2 sensor is to respond ef-
fectively to a change in PO2 rather than an absolute value. For
example, how much does the sensor's activity change when
confronted by a 50% fall in PO2 from normoxia, a challenge
commonly used in investigations of acute and long term hy-
poxia? Fig. 5 shows a theoretical model based on an assumption
of hyperbolic kinetics and the reported P50s of the O2 sensing
mechanisms previously discussed. Panel A shows the predicted
activity of each sensor against PO2; for comparison with Fig. 4
the approximate alveolar, arterial, tissue and cytosolic PO2
values are shown. Note that as all of these sensors utilise O2
their activity will fall as PO2 is reduced, assuming other sub-
strates and co-factors remain constant (see discussion of NOX
and CYP above), although that of their distal signalling mecha-
nisms may not (e.g. HIF-1 stabilisation, mitochondrial ROS
generation). In contrast, panel B shows the predicted change in
activity in response to a 50% reduction in PO2 from a range of
initial PO2s.
Perusal of these two plots is enlightening. In particular, this
admittedly simplistic model suggests that although the absolute
activity of PHDs and FIH-1 would be very low in the cytosol,
the relevant location for their proposed action, halving the PO2
causes an almost 50% reduction in activity, and that this dy-
namic efficiency is retained over a wide range of PO2. The fact
that the absolute activity of PHDs is low is not necessarily
inconsistent with the fact that there is little HIF-1 expression in
normoxia [102,110], as PHDs may be sufficiently in excess to
cause near complete degradation even at this low activity. A
similar consideration applies to FIH-1. At the other extreme the
predicted activity of COX, and particularly of HO-2, remains
close to 100% as the PO2 falls well below estimated cytosolic
values, and even though the mitochondrial PO2 might be ex-
pected to be lower than this, even a reduction in PO2 from 0.3 to
0.15 kPa would only reduce the predicted COX activity by
∼15%. This does not appear to correlate well with the reported
sensitivity of O2 sensitive tissues where inhibition of oxidative
phosphorylation or HO-2 activity has been proposed as the
initial event in O2 sensing.
4.3. Correlation of sensor and effector O2 sensitivities
Fig. 6 illustrates example responses to decreasing PO2 for
various O2 sensitive preparations, using data derived and extra-
polated from the literature. These specific preparations were
chosen as they were either perfused (carotid body [121], lungs
[122]), or if superfused the diffusional distances were equiva-
lent to those in vivo (thin walled small pulmonary arteries
[40,123]); for these preparations the values of PO2 shown on the
abscissa reflects that within blood vessels. The neonatal AMC
preparation on the other hand consisted of superfused clusters of
5–30 freshly isolated cells [124], and the superfusate PO2 isprobably more representative of that in tissue. The HeLa cells
were studied under closely controlled conditions in a tonometer,
and in the presence of cyanide to block mitochondrial O2
consumption and thus minimise the O2 gradient across the cell
membrane; the PO2 can therefore be considered equivalent to
that of the cytosol [112]. Thus the response curves for carotid
body, pulmonary artery and lung would be shifted to the left by
a factor of ∼5–10, and that for AMCs by ∼2 if the abscissa
referred to cytosolic PO2 (see Fig. 4 and [120]). Whilst these are
broad approximations, it is notable that the AMC response
Fig. 6. Depiction of the response of some classical O2 sensitive tissues or mechanisms to changes in PO2. The data used for generating the figure were derived and
interpolated from examples in the literature; symbols are for identification only, and do not necessarily reflect data points. The preparations and their recorded
responses are: elevation of intracellular [Ca2+] in superfused AMCs derived from neonatal rats, estimated using Fura-2 or Indo-1 [124]; increase in NADH
autofluorescence in small intrapulmonary arteries of rat [40] (and own unpublished observations, Ward, Baxter and Aaronson); constriction of pressurised small
intrapulmonary arteries of pig [123]; elevation of pulmonary artery pressure in blood-perfused lungs of pig to a step-wise reduction in PO2 [122]; steady-state
responses of single afferent nerve fibres from the carotid body of cats, perfused in situ [121]; Western blot estimation of HIF-1α expression in HeLa cells maintained in
a tonometer at the given PO2 for 4 h, in the presence of 1 mM cyanide to minimise O2 consumption and gradients [112].
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flecting the correspondingly lower arterial PO2 in the fetus and
at parturition [3].
The relationships between PO2 and final response of carotid
body (afferent nerve activity), pulmonary artery (constriction)
and perfused lungs (increase in pulmonary artery pressure)
span a physiologically appropriate range of PO2 and are very
steep (Fig. 6), suggesting the coupling function between sensor
and response is highly non-linear. This is not particularly
surprising considering the number and complexity of potential
intermediate pathways, especially for example if AMP kinase is
involved, which responds according to at least the square of the
ADP/ATP ratio [41]. An important point that is often over-
looked is that the greater the power of the coupling function the
more the P50 of the response will move to the right of that of its
sensor, though with no change in threshold. The increase in
mitochondrial NADH with decreasing PO2, as shown in Fig.6
and as estimated from autofluorescence in intact small pulmo-
nary arteries [27,40], is probably a relatively direct reflection of
inhibition of mitochondrial function (see above). Assuming that
the latter is indeed the basis of O2 sensing in PASMCs, then
comparison of the NADH autofluorescence response curve in
small pulmonary arteries with that for constriction in a similar
preparation (Fig. 6) might be said to exemplify the effect of an
amplifying coupling function, with a shift to the right of the P50
for constriction but no change in threshold. A high coupling
function endows a physiological advantage as it increases sen-
sitivity over a narrow range, a functional requirement for the
control of ventilation and HPV.
The P50 of the NADH autofluorescence response shown is
∼2.8 kPa PO2 in superfusate (Fig. 6). Even if it is assumed thatthe cytosolic PO2 is as little as 10% of that in the superfusate
(Fig. 4) and the P50 is corrected accordingly to 0.28 kPa, this is
still ∼40 times the reported P50 for COX of 0.07 kPa [21].
Likewise, in glomus cells even moderate hypoxia has been
shown to increase NADH autofluorescence and reduce mito-
chondrial flavoproteins and ΔΨm [10,33]. By comparison, the
P50 for AMCs is ∼0.3 kPa [124]; once corrected for cytosolic
PO2 this shows good correlation with the P50 of COX, as
predicted if the latter is the O2 sensor in these cells. This implies
that the mitochondria of carotid body glomus cells and
PASMCs must either be specialised so that they are affected
by higher levels of PO2 than in other tissues, or that these tissues
contain modulating influences that effectively increase the P50.
The large divergence between the P50 reported for carotid
body (∼0.85 kPa, as corrected for cytosolic PO2) [121] and that
for HO-2 (0.0012 kPa) [84] is considerably more severe than
that for COX, perhaps fatally so for the hypothesis that HO-2
acts as the O2 sensor in glomus cells. Nevertheless, HO-2
dependent responses were elicited by moderate hypoxia (3–
5 kPa) [85]. This implies either that the P50 for HO-2 is very
much higher when it is associated with BK channels, or that the
published value for the P50 is simply incorrect or species
dependent, or alternatively that HO-2 does not act as the sensor
itself, but via CO facilitates or permits sensing by the BK
channels themselves. Only further studies will determine which
if any of these options is correct.
The PO2 response curve for HIF-1α expression deserves
special mention, as in contrast to the other mechanisms dis-
cussed the P50 of the response (∼1.7 kPa PO2) is far lower than
that of the sensor (PHDs; ∼22 kPa PO2), rather than higher. In
addition, HIF-1α expression increases in a close to exponential
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ship between PHD activity and PO2 is not far from linear over
the same range (Fig. 5A).
This has been cited as evidence that the rate of HIF-1α
degradation cannot be simply a function of the effect of PO2 on
PHD activity, but must instead be an integrated response,
possibly involving NADPH oxidase or mitochondrial-derived
ROS, and the effect of these and hypoxia on the necessary co-
factors for PHD hydroxylation of HIF-1α, specifically ascor-
bate, Fe(II) and 2-oxoglutarate [10]. The arguments for such an
integrated model are compelling, though the data shown in
Fig. 6 for example were obtained following inhibition of oxi-
dative phosphorylation with 1 mM cyanide [112]. In any case,
the expression of HIF-1α cannot be expected to have a simple
relationship with PO2, as it is hydroxylated HIF-1α (which is
then rapidly degraded) that is the product of the PHD-catalysed
reaction, and expression of HIF-1α will depend on the balance
between synthesis and degradation (see above). Moreover, the
rate of hydroxylation of HIF-1α will depend not only on the
concentrations of its two substrates, O2 and HIF-1α, but also on
those of its required co-factors, which are not necessarily in
excess, especially in hypoxia [10]. Doubtless an appropriate
kinetic model could be developed to define the relationship
between PHD activity, [O2] and HIF-1α expression, but this is
beyond the scope of this review (and its author). Notwithstand-
ing the above, a notable though almost certainly serendipitous
point is that reducing the cytosolic PO2 from 2 to 1 kPa results
in an approximate doubling of HIF-1α expression (Fig. 6), and
an approximate halving of PHD activity (Fig. 5B).
4.4. Modulation of O2 sensitivity of the sensor
There is no need to consider modulation of the O2 sensitivity
of PHDs and FIH-1, and probably CYP, as it has already been
shown that these can be effective over a wide range of PO2 and
within their operational locus (the cytosol). As discussed above
however there is a clear dichotomy between the P50s for COX
and HO-2 and their proposed effectors in glomus cells and
PASMCs, though not for COX in AMCs. There is little or no
information available on factors that might modify the P50 for
HO-2, so this will not be discussed further. However, a number
of factors are known to alter the effective P50 for COX, and
some that could potentially affect mitochondrial signalling in
hypoxia that do not necessarily involve COX.
The first consideration is that values for the P50 for COX
commonly quoted in discussions of mitochondrial O2 sensing
are derived from tissues other than the classical O2 sensitive
tissues of glomus cell and PASMC (as indeed I have done here),
as these are the only ones available. However there is strong
evidence that mitochondria in glomus cells and PASMCs have a
lower affinity for O2 (i.e. the P50 is greater) than in non-O2
sensing tissues or indeed AMCs, and may also differ in terms of
basal respiratory rate and ΔΨm [10,27,33,36,125], and a low
O2 affinity cytochrome aa3 has been implicated in glomus cells
[126,127]. The effective O2 affinity of COX is also proportional
to its relative expression compared to that of proximal com-
ponents of the ETC; a low relative expression will not onlyincrease the P50, but also make the proximal ETC more reduced
and promote formation of ROS [21,22]. Interestingly, the mito-
chondrial P50 is increased 2–3 fold above normal in cells from
patients with Leigh syndrome who suffer from mutations in
SURF1, and consequently defective assembly of COX [128].
The P50 of COX can also be affected by cytosolic mediators,
potentially allowing dynamic regulation. NO is a known modu-
lator of mitochondrial function, and has been shown to compete
with O2 at cytochrome aa3, increasing the effective P50 and
promoting ROS production [129]. It has been suggested that
this mechanism allows the systemic circulation to respond to
moderate hypoxia and vasodilate [130]. However, inhibition of
NO synthase tends to augment both the response of glomus cells
to hypoxia and HPV [16,131]. H2S is believed to be an endo-
genous “gasotransmitter” with functional similarities to NO and
CO; its synthesis and metabolism are highly redox dependent
[132]. It has recently been suggested that H2S may be involved
in O2 sensing in the pulmonary and systemic vasculature, based
on evidence that inhibition of its synthesis suppresses the re-
sponse to hypoxia, whereas exogenous H2S mimics hypoxia
[133]. Like NO, H2S also binds to cytochrome aa3 and com-
petes with O2 [134], and promotes mitochondrial ROS produc-
tion [135]. However, as yet there is insufficient information to
come to any form of decision as to the role of H2S in O2 sensing.
Finally, two other mechanisms may affect the effective P50
for mitochondrial redox state and/or ROS production, without
necessarily affecting COX electron flux or ATP production. The
first is the “near equilibrium” hypothesis, which has already
been alluded to and predicts that cytochrome c and the proximal
ETC become more reduced even well above the P50 for COX as
the PO2 falls [23,24]. The second, proposed by Schumacker
[13,136], invokes hypoxia-induced changes in the lipid–protein
structure of the mitochondrial inner membrane such that there is
either i) a shift of ROS production and extrusion from the Qi to
the Qo side of complex III, ii) an increase in ubisemiquinone
lifetime in complex III (and hence a greater likelihood of
electron transfer to O2), or iii) increased access of O2 to ubi-
semiquinone. As yet, there is no strong evidence for or against
these interesting hypotheses; they do however raise the poten-
tially important concept of a separation of mitochondrial O2
sensing mechanisms from those of energy production.
5. Conclusion
This review has attempted to put some of the keymechanisms
that have been proposed to underlie O2 sensing into the context
of the environment in which they are thought to function. This is
rarely considered in discussions of O2 sensor function, but is
vital if any sense is to be made of correlations between the P50 of
sensor, signalling mediators, and the ultimate response. Whilst
admittedly some of the interpretations are based on assumptions
that may prove to be of limited validity, I believe that these
provide a reasonably accurate view of some of the strengths and
weaknesses of current hypotheses of O2 sensing in what may be
regarded as their natural habitat. In particular, the high P50s for
PHDs and FIH-1 should not be of concern when considering
their role in O2 sensing, as they have a sufficient dynamic
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limitations for PHDs at low PO2 might conceivably accelerate
HIF-1 stabilisation. In contrast the role of HO-2 as an O2 sensor
would seem to be severely limited by its (allegedly) extremely
high affinity for O2. Whilst the same criticism might be levelled
at mitochondria, there is strong evidence that at least in glomus
cells and PASMCs the effective O2 affinity of COX is
significantly less than in most other tissues.
The bulk of the evidence supports the concept that mito-
chondria act as the O2 sensor in the classical O2 sensing tissues
of carotid body, pulmonary artery and AMCs, though not in
NEBs. However, the means by which hypoxia-induced altera-
tions in mitochondrial function are translated into a functional
response clearly differ, involving changes in energy state and
probably AMP kinase activity in glomus cells, a fall in ROS
production in AMCs, and, I would suggest, an increase in ROS
production in PASMCs. Whilst at first glance the latter two
appear incompatible, consideration of the operation of the ETC
and the effect of changes in coupling between proximal and
distal components demonstrate that they are both entirely fea-
sible. As previously suggested, this implies that the mitochon-
dria of these specialised O2 sensing tissues are adapted to
purpose, and under these conditions should be regarded as
signalling organelles rather than the power house of the cell.
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